Location History:
- Ahmedabad, IN (2015 - 2017)
- Gujarat, IN (2015 - 2018)
Company Filing History:
Years Active: 2015-2018
Title: Sunilendu Bhushan Roy: Innovator in Pharmaceutical Compositions
Introduction
Sunilendu Bhushan Roy is a prominent inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating skin conditions such as acne and psoriasis. With a total of 8 patents to his name, Roy's work exemplifies innovation and dedication to improving therapeutic options.
Latest Patents
One of his latest patents focuses on pharmaceutical compositions of anti-acne agents. This invention relates to stable pharmaceutical formulations designed for the treatment of acne. The compositions are formulated with other pharmaceutically acceptable excipients, ensuring excellent stability, greater permeability, and enhanced therapeutic efficacy. Another notable patent involves topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis. These stable formulations may include nanoemulsions with nano-sized droplets of anti-psoriasis agents, such as clobetasol and salicylic acid, which exhibit improved permeability and bioavailability.
Career Highlights
Sunilendu Bhushan Roy is associated with Cadila Healthcare Limited, a leading pharmaceutical company in India. His work at Cadila has allowed him to focus on innovative solutions that address common dermatological issues. His contributions have not only advanced the field but have also provided patients with more effective treatment options.
Collaborations
Throughout his career, Roy has collaborated with notable colleagues, including Jay Shantilal Kothari and Shafiq Sheikh. These collaborations have fostered a productive environment for research and development, leading to the successful creation of impactful pharmaceutical products.
Conclusion
Sunilendu Bhushan Roy's innovative work in pharmaceutical compositions has made a significant impact on the treatment of acne and psoriasis. His dedication to research and development continues to enhance therapeutic options for patients.